NIR Fluorescence-guided Tumor Surgery: New Strategies for the Use of Indocyanine Green

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2019 Oct 3

PMID 31576126

Citations 69

Authors

Claire Egloff-Juras

Lina Bezdetnaya

Gilles Dolivet

Henri-Pierre Lassalle

Affiliations

Soon will be listed here.

Abstract

Surgery is the frontline treatment for a large number of cancers. The objective of these excisional surgeries is the complete removal of the primary tumor with sufficient safety margins. Removal of the entire tumor is essential to improve the chances of a full recovery. To help surgeons achieve this objective, near-infrared fluorescence-guided surgical techniques are of great interest. The concomitant use of fluorescence and indocyanine green (ICG) has proved effective in the identification and characterization of tumors. Moreover, ICG is authorized by the Food and Drug Administration and the European Medicines Agency and is therefore the subject of a large number of studies. ICG is one of the most commonly used fluorophores in near-infrared fluorescence-guided techniques. However, it also has some disadvantages, such as limited photostability, a moderate fluorescence quantum yield, a high plasma protein binding rate, and undesired aggregation in aqueous solution. In addition, ICG does not specifically target tumor cells. One way to exploit the capabilities of ICG while offsetting these drawbacks is to develop high-performance near-infrared nanocomplexes formulated with ICG (with high selectivity for tumors, high tumor-to-background ratios, and minimal toxicity). In this review article, we focus on recent developments in ICG complexation strategies to improve near-infrared fluorescence-guided tumor surgery. We describe targeted and nontargeted ICG nanoparticle models and ICG complexation with targeting agents.

Citing Articles

Fluorescence-guided Surgery for Hepatocellular Carcinoma: From Clinical Practice to Laboratories.

Xiao T, Chen D, Peng L, Li Z, Pan W, Dong Y J Clin Transl Hepatol. 2025; 13(3):216-232.

PMID: 40078203 PMC: 11894393. DOI: 10.14218/JCTH.2024.00375.

The Medical Basis for the Photoluminescence of Indocyanine Green.

Mytych W, Bartusik-Aebisher D, Aebisher D Molecules. 2025; 30(4).

PMID: 40005197 PMC: 11858079. DOI: 10.3390/molecules30040888.

Enhanced Lymph Node Detection in Colon Cancer Using Indocyanine Green Fluorescence: A Systematic Review of Studies from 2020 Onwards.

Negrut R, Cote A, Feder B, Bodog F, Maghiar A J Pers Med. 2025; 15(2).

PMID: 39997331 PMC: 11855940. DOI: 10.3390/jpm15020054.

Indocyanine Green as a Marker for Tissue Ischemia in Spinal Tumor Resections and Extended Revisions: A Technical Note.

Ward M, Schneider D, Brown E, Maity A, Obeng-Gyasi B, Ber R J Clin Med. 2025; 14(3).

PMID: 39941585 PMC: 11818688. DOI: 10.3390/jcm14030914.

The optimization and application of photodynamic diagnosis and autofluorescence imaging in tumor diagnosis and guided surgery: current status and future prospects.

Wan W, Liu H, Zou J, Xie T, Zhang G, Ying W Front Oncol. 2025; 14():1503404.

PMID: 39845324 PMC: 11750647. DOI: 10.3389/fonc.2024.1503404.

References

Sano K, Nakajima T, Miyazaki K, Ohuchi Y, Ikegami T, Choyke P . Short PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probes. Bioconjug Chem. 2013; 24(5):811-6. PMC: 3674550. DOI: 10.1021/bc400050k. View

Sano K, Nakajima T, Ali T, Bartlett D, Wu A, Kim I . Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: consideration of fluorescent catabolite kinetics on molecular imaging. J Biomed Opt. 2013; 18(10):101304. PMC: 3677842. DOI: 10.1117/1.JBO.18.10.101304. View

Steffensen K, Waldstrom M, Andersen R, Olsen D, Jeppesen U, Knudsen H . Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors. Int J Oncol. 2008; 33(1):195-204. View

Merian J, Boisgard R, Bayle P, Bardet M, Tavitian B, Texier I . Comparative biodistribution in mice of cyanine dyes loaded in lipid nanoparticles. Eur J Pharm Biopharm. 2015; 93:1-10. DOI: 10.1016/j.ejpb.2015.03.019. View

Ashokan A, Gowd G, Somasundaram V, Bhupathi A, Peethambaran R, Unni A . Multifunctional calcium phosphate nano-contrast agent for combined nuclear, magnetic and near-infrared in vivo imaging. Biomaterials. 2013; 34(29):7143-57. DOI: 10.1016/j.biomaterials.2013.05.077. View

Zalipsky S . Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. Bioconjug Chem. 1995; 6(2):150-65. DOI: 10.1021/bc00032a002. View

Miller K, Siegel R, Lin C, Mariotto A, Kramer J, Rowland J . Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016; 66(4):271-89. DOI: 10.3322/caac.21349. View

Hashizume H, Baluk P, Morikawa S, McLean J, Thurston G, Roberge S . Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol. 2000; 156(4):1363-80. PMC: 1876882. DOI: 10.1016/S0002-9440(10)65006-7. View

Fang J, Nakamura H, Maeda H . The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2010; 63(3):136-51. DOI: 10.1016/j.addr.2010.04.009. View

10.

Hill T, Abdulahad A, Kelkar S, Marini F, Long T, Provenzale J . Indocyanine green-loaded nanoparticles for image-guided tumor surgery. Bioconjug Chem. 2015; 26(2):294-303. PMC: 4373659. DOI: 10.1021/bc5005679. View

11.

Iyer A, Khaled G, Fang J, Maeda H . Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today. 2006; 11(17-18):812-8. DOI: 10.1016/j.drudis.2006.07.005. View

12.

Chen W, Ayala-Orozco C, Biswal N, Perez-Torres C, Bartels M, Bardhan R . Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells. Nanomedicine (Lond). 2013; 9(8):1209-22. PMC: 4051872. DOI: 10.2217/nnm.13.84. View

13.

Yokoyama J, Fujimaki M, Ohba S, Anzai T, Yoshii R, Ito S . A feasibility study of NIR fluorescent image-guided surgery in head and neck cancer based on the assessment of optimum surgical time as revealed through dynamic imaging. Onco Targets Ther. 2013; 6:325-30. PMC: 3623571. DOI: 10.2147/OTT.S42006. View

14.

Zheng X, Xing D, Zhou F, Wu B, Chen W . Indocyanine green-containing nanostructure as near infrared dual-functional targeting probes for optical imaging and photothermal therapy. Mol Pharm. 2011; 8(2):447-56. DOI: 10.1021/mp100301t. View

15.

Kesavan K, Ratliff J, Johnson E, Dahlberg W, Asara J, Misra P . Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects. J Biol Chem. 2009; 285(7):4366-74. PMC: 2836041. DOI: 10.1074/jbc.M109.066092. View

16.

Bahmani B, Guerrero Y, Bacon D, Kundra V, Vullev V, Anvari B . Functionalized polymeric nanoparticles loaded with indocyanine green as theranostic materials for targeted molecular near infrared fluorescence imaging and photothermal destruction of ovarian cancer cells. Lasers Surg Med. 2014; 46(7):582-92. DOI: 10.1002/lsm.22269. View

17.

Mujumdar R, Ernst L, Mujumdar S, Waggoner A . Cyanine dye labeling reagents containing isothiocyanate groups. Cytometry. 1989; 10(1):11-9. DOI: 10.1002/cyto.990100104. View

18.

Choi H, Frangioni J . Nanoparticles for biomedical imaging: fundamentals of clinical translation. Mol Imaging. 2010; 9(6):291-310. PMC: 3017480. View

19.

Nagaya T, Nakamura Y, Choyke P, Kobayashi H . Fluorescence-Guided Surgery. Front Oncol. 2018; 7:314. PMC: 5743791. DOI: 10.3389/fonc.2017.00314. View

20.

Souris J, Lee C, Cheng S, Chen C, Yang C, Ho J . Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials. 2010; 31(21):5564-74. PMC: 2875342. DOI: 10.1016/j.biomaterials.2010.03.048. View